- BIST10011,430-2.49%
- USD49.45+0.05%
- EUR55.62+0.37%
- GOLD4,160.50+0.01%
- INTEREST37.00%-1.00
- BITCOIN82,0080.00%
- October 20, 202616°
- BIST10011,430-2.49%
- USD49.45+0.05%
- EUR55.62+0.37%
- GOLD4,160.50+0.01%
- INTEREST37.00%-1.00
- BITCOIN82,0080.00%
- October 20, 202616°
Russia grants funding to Sechenov University and R-Farm to develop a CRISPR-based hepatitis B drug
The Russian Science Foundation has provided funding to a project by Sechenov University and the pharmaceutical company R-Farm to develop a new drug for chronic hepatitis B treatment using the CRISPR-Cas9 gene editing method. The grant will support the transition of the drug from the laboratory stage to industrial prototype production.
Stay Updated with RuskiGazeta
Subscribe to be informed about special news, developments and announcements. We will keep you informed.
By signing up, you agree to our Privacy Policy
